- Home
- DOMH vs ADXN Comparison
DOMH vs ADXN Comparison
Compare DOMH & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- ADXN
- Stock Information
- Founded
- DOMH 1967
- ADXN 2002
- Country
- DOMH United States
- ADXN Switzerland
- Employees
- DOMH N/A
- ADXN N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- DOMH Health Care
- ADXN Health Care
- Exchange
- DOMH Nasdaq
- ADXN Nasdaq
- Market Cap
- DOMH 94.0M
- ADXN 8.5M
- IPO Year
- DOMH N/A
- ADXN N/A
- Fundamental
- Price
- DOMH $4.87
- ADXN $8.71
- Analyst Decision
- DOMH
- ADXN
- Analyst Count
- DOMH 0
- ADXN 0
- Target Price
- DOMH N/A
- ADXN N/A
- AVG Volume (30 Days)
- DOMH 223.1K
- ADXN 24.6K
- Earning Date
- DOMH 11-12-2025
- ADXN 11-21-2025
- Dividend Yield
- DOMH 11.20%
- ADXN N/A
- EPS Growth
- DOMH N/A
- ADXN N/A
- EPS
- DOMH N/A
- ADXN N/A
- Revenue
- DOMH $52,811,000.00
- ADXN $210,347.00
- Revenue This Year
- DOMH N/A
- ADXN $86.57
- Revenue Next Year
- DOMH N/A
- ADXN N/A
- P/E Ratio
- DOMH N/A
- ADXN N/A
- Revenue Growth
- DOMH 455.38
- ADXN N/A
- 52 Week Low
- DOMH $0.83
- ADXN $6.51
- 52 Week High
- DOMH $13.58
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- DOMH 36.14
- ADXN 46.04
- Support Level
- DOMH $4.95
- ADXN $9.01
- Resistance Level
- DOMH $6.21
- ADXN $9.79
- Average True Range (ATR)
- DOMH 0.38
- ADXN 0.78
- MACD
- DOMH -0.11
- ADXN -0.07
- Stochastic Oscillator
- DOMH 5.88
- ADXN 5.23
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.